Oncology Today with Dr Neil Love cover image

Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue

Oncology Today with Dr Neil Love

00:00

Niraprib and the Knee-Allegent

I think we look at when to start bev. If somebody comes in, big plural of fusions, the sitees, I'm going to give bev even in the knee-allegent. And for patients who are Braco wild type, HRD negative, would you ever consider adding niraprib to the bev? You know, we have some data that shows it safe. It is an option. The issue is the safety and hypertension need to make sure they're checking their blood pressure a couple of times a day,. particularly with nirap rib and the bev.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app